Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in Papua New Guinea using an extended ligase detection reaction fluorescent microsphere assay

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 2, 2011, Pages 798-805

  Wong, Rina P M ^a   Karunajeewa, Harin ^a   Mueller, Ivo ^b   Siba, Peter ^b   Zimmerman, Peter A ^c   Davis, Timothy M E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; DIHYDROARTEMISININ PLUS PIPERAQUINE; LIGASE; MICROSPHERE;

ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; CODON; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FLUORESCENCE; GENE MUTATION; HAPLOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; INFANT; LIGASE DETECTION REACTION FLUORESCENT MICROSPHERE ASSAY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; PAPUA NEW GUINEA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTIMALARIALS; CHILD, PRESCHOOL; DRUG RESISTANCE; FLUORESCENCE; HUMANS; INFANT; LIGASES; MALARIA, FALCIPARUM; MICROSPHERES; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PAPUA NEW GUINEA; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTOZOAN PROTEINS;

EID: 78751681563     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00939-10     Document Type: Article

References (49)

1. Alifrangis, M., et al. 2005. A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction- and enzymelinked immunosorbent assay-based technology. Am. J. Trop. Med. Hyg. 72:155-162.
2. Bacon, D. J., et al. 2009. Effects of point mutations in Plasmodium falciparum dihydrofolate reductase and dihydropterate synthase genes on clinical outcomes and in vitro susceptibility to sulfadoxine and pyrimethamine. PLoS One 4:e6762.
3. Basco, L. K., M. Ndounga, V. F. Ngane, and G. Soula. 2002. Molecular epidemiology of malaria in Cameroon. XIV. Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene sequences of isolates before and after chloroquine treatment. Am. J. Trop. Med. Hyg. 67:392-395.
4. Carnevale, E. P., et al. 2007. A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance. J. Clin. Microbiol. 45:752-761.
5. Casey, G. J., et al. 2004. Molecular analysis of Plasmodium falciparum from drug treatment failure patients in Papua New Guinea. Am. J. Trop. Med. Hyg. 70:251-255.
6. Cowman, A. F., D. Galatis, and K. J. Thompson. 1994. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc. Natl. Acad. Sci. U. S. A. 91:1143-1147.
7. Cowman, A. F., M. J. Morry, B. A. Biggs, G. A. Cross, and S. J. Foote. 1988. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reducatase-thymidylate synthase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A. 85:9109-9113.
8. Crameri, A., et al. 2007. Rapid microarray-based method for monitoring of all currently known single-nucleotide polymorphisms associated with parasite resistance to antimalarial drugs. J. Clin. Microbiol. 45:3685-3691.
9. DaRe, J. T., D. P. Kouri, P. A. Zimmerman, and P. J. Thomas. 2010. Differentiating Plasmodium falciparum alleles by transforming Cartesian X,Y data to polar coordinates. BMC Genet. 11:57.
10. DaRe, J. T., et al. 2007. Microsatellite polymorphism within pfcrt provides evidence of continuing evolution of chloroquine-resistant alleles in Papua New Guinea. Malar. J. 6:34.
11. Darlow, B., H. Vrbova, J. Stace, P. Heywood, and M. P. Alpers. 1980. Fansidar-resistant falciparum malaria in Papua New Guinea. Lancet ii:1243.
12. Dokomajilar, C., S. L. Nsobya, B. Greenhouse, P. J. Rosenthal, and G. Dorsey. 2006. Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob. Agents Chemother. 50:1893-1895.
13. Duraisingh, M. T., J. Curtis, and D. C. Warhurst. 1998. Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp. Parasitol. 89:1-8.
14. Farcas, G. A., R. Soeller, K. Zhong, A. Zahirieh, and K. C. Kain. 2006. Real-time polymerase chain reaction assay for the rapid detection and characterization of chloroquine-resistant Plasmodium falciparum malaria in returned travelers. Clin. Infect. Dis. 42:622-627.
15. Fidock, D. A., et al. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein pfcrt and evidence for their role in chloroquine resistance. Mol. Cell 6:861-871.
16. Foote, S. J., et al. 1990. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345:255-258.
17. Gomez-Saladin, E., et al. 1999. Plasmodium falciparum mdr1 mutations and in vivo chloroquine resistance in Indonesia. Am. J. Trop. Med. Hyg. 61:240-244.
18. Grimmond, T. R., K. O. Donovan, and I. D. Riley. 1976. Chloroquine resistant malaria in Papua New Guinea. P. N. G. Med. J. 19:184-185.
19. Happi, C. T., et al. 2008. Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemetherlumefantrine in Nigerian children with uncomplicated falciparum malaria. Antimicrob. Agents Chemother. 53:888-895.
20. Humphreys, G. S., et al. 2007. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrob. Agents Chemother. 51:991-997.
21. Karunajeewa, H. A., et al. 2008. A trial of combination antimalarial therapies in children from Papua New Guinea. N. Engl. J. Med. 359:2545-2557.
22. Keen, J., et al. 2007. Real-time PCR assay for rapid detection and analysis of pfcrt haplotypes of chloroquine-resistant Plasmodium falciparum isolates from India. J. Clin. Microbiol. 45:2889-2893.
23. Lim, P., et al. 2003. pfcrt polymorphism and chloroquine resistance in Plasmodium falciparum strains isolated in Cambodia. Antimicrob. Agents Chemother. 47:87-94.
24. Marfurt, J., et al. 2007. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea. Am. J. Trop. Med. Hyg. 77:947-954.
25. Marfurt, J., et al. 2008. The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea. Malar. J. 7:61.
26. McNamara, D. T., et al. 2006. Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent microsphere-based assay. Am. J. Trop. Med. Hyg. 74:413-421.
27. Mehlotra, R. K., et al. 2001. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc. Natl. Acad. Sci. U. S. A. 98:12689-12694.
28. Mehlotra, R. K., et al. 2005. Insight into the early spread of chloroquine-resistant Plasmodium falciparum infections in Papua New Guinea. J. Infect. Dis. 192:2174-2179.
29. Mehlotra, R. K., et al. 2008. Disconcordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum. Antimicrob. Agents Chemother. 52:2212-2222.
30. Mita, T., et al. 2006. Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/ pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea. Infect. Genet. Evol. 6:447-452.
31. Nawaz, F., S. L. Nsobya, M. Kiggundu, M. Joloba, and P. J. Rosenthal. 2009. Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda. J. Infect. Dis. 200:1650-1657.
32. Nsobya, S. L., C. Dokomajilar, M. Joloba, G. Dorsey, and P. J. Rosenthal. 2007. Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda. Antimicrob. Agents Chemother. 51:3023-3025.
33. Peel, S. A., P. Bright, B. Yount, J. Handy, and R. S. Baric. 1994. A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 51:648-658.
34. Peterson, D. S., D. Walliker, and T. E. Wellems. 1988. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl. Acad. Sci. U. S. A. 85:9114-9118.
35. Pickard, A. L., et al. 2003. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob. Agents Chemother. 47:2418-2423.
36. Ranford-Cartwright, L. C., K. L. Johnston, A. M. Abdel-Muhsin, B. K. Khan, and H. A. Babiker. 2002. Critical comparison of molecular genotyping methods for detection of drug-resistant Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 96:568-572.
37. Reed, M. B., K. J. Saliba, S. R. Caruana, K. Kirk, and A. F. Cowman. 2000. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403:906-909.
38. Reeder, J., et al. 1996. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. Am. J. Trop. Med. Hyg. 55:209-213.
39. Rungsihirunrat, K., W. Chaijareonkul, A. Seugorn, K. Na-Bangchang, and S. Thaithong. 2009. Association between chloroquine resistance phenotypes and point mutations in pfcrt and pfmdr1 in Plasmodium falciparum isolates from Thailand. Acta Trop. 109:37-40.
40. Sa, J. M., et al. 2009. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc. Natl. Acad. Sci. U. S. A. 106:18883-18889.
41. Schoepflin, S., et al. 2008. Heterogeneous distribution of Plasmodium falciparum drug resistance haplotypes in subsets of the host population. Malar. J. 7:78.
42. Schoepflin, S., et al. 2009. Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping. Malar. J. 8:250.
43. Talisuna, A. O., et al. 2004. Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children. Trop. Med. Int. Health 9:222-229.
44. Triglia, T., and A. F. Cowman. 1999. The mechanism of resistance to sulfa drugs in Plasmodium falciparum. Drug Resist. 2:15-19.
45. Triglia, T., and A. F. Cowman. 1994. Primary structure and expression of dihydropteroate synthetase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A. 91:7149-7153.
46. Veiga, M. I., P. E. Ferreira, A. Bjorkman, and J. P. Gil. 2006. Multiplex PCR-RFLP methods for pfcrt, pfmdr1 and pfdhfr mutations in Plasmodium falciparum. Mol. Cell. Probes 20:100-104.
47. Wong, R. P. M., H. Karunajeewa, I. Mueller, P. Siba, E. P. Carnevale, P. A. Zimmerman, and T. M. E. Davis. 2010. Novel molecular detection of drug resistance markers in Plasmodium falciparum from Papua New Guinean children with uncomplicated malaria, abstr. 72.005. Proceedings of the 14th International Congress on Infectious Diseases. International Society for Infectious Diseases, Brookline, MA.
48. World Health Organization. 2003. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria, vol. WHO/HTM/RBM/2003.50. World Health Organization, Geneva, Switzerland.
49. Yang, Z., et al. 2007. Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province, China. Trop. Med. Int. Health 12:1051-1060.